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Abstract
Background: Interphase chromosome-specific multicolor banding (ICS-MCB) has 
been developed for studying whole chromosomes in interphase nuclei at any stage of 
the cell cycle at molecular resolution. Previously, important biomedical discoveries 
have been made using the technique. In the postgenomic era, a need appears to exist 
for a reevaluation of molecular cytogenetic techniques, including ICS-MCB, which 
seems to take a well-deserved place. Aim of the study: The aim of the present study 
is to address the applicability of ICS-MCB for studying neurodevelopmental and 
neurodegenerative disorders. Conclusions: A brief overview of previous ICS-MCB 
applications demonstrates that the technique may provide an appreciable amount of 
unique data on chromosome abnormalities and organization in interphase nuclei. Fur­
thermore, the technique offers opportunities for evaluating these phenomena in the 
diseased human brain. Such opportunity seems to be critical for unraveling molecular 
and cellular mechanisms of neurodevelopmental and neurodegenerative disorders. 
Therefore, we conclude that ICS-MCB may represent an important part of molecular 
and cellular studies of neurodevelopmental and neurodegenerative disorders. 
Keywords: chromosome; chromosome instability; interphase nucleus; neurodegen- 
erative disorders; neurodevelopmental disorders
1 This article has been partially communicated at the congress dedicated to the memory o f  Prof. Yuri Yurov (Medical
genomics: multidisciplinary aspects) held in St. Petersburg (26-29 March 2019).
Краткое сообщение
Short communication
Научные результ ат ы биомедицинских исследований. 2019. Т.5, №3. С. 4-9
Research Results in Biomedicine. 2019. Vol.5, №3. Р. 4-9
5
Acknowledgements: Ivan I. Iourov, Svetlana G. Vorsanova and Luis Alberto Men- 
dez-Rosado are supported by RFBR and CITMA according to the research project 
№18-515-34005.
For citation: Iourov IY, Liehr T, Vorsanova SG, et al. The applicability of inter­
phase chromosome-specific multicolor banding (ICS-MCB) for studying neurode- 
velopmental and neurodegenerative disorders. Research Results in Biomedicine. 
2019;5(3):4-9. DOI: 10.18413/2658-6533-2019-5-3-0-1
Introduction. Neurodevelopmental and 
neurodegenerative disorders have been sys­
tematically associated with genomic varia­
tions (i.e. chromosome abnormalities, copy 
number variations and single-gene mutations) 
[1-4]. Besides, genomic variations are com­
monly mosaic. Furthermore, somatic mosai­
cism is likely to be an important genetic 
mechanism for brain diseases. The most 
common types of somatic genomic variations 
are chromosomal mosaicism and instability 
[1, 3, 5-7]. However, despite these observa­
tions, somatic chromosomal mosaicism is still 
under observed. This is more likely because 
of unacceptable neglect to techniques availa­
ble for studying intercellular genome variabil­
ity [1, 7]. Fortunately, molecular cytogenetics 
does provide approaches towards studying 
genome variations at chromosomal level 
[8, 9]. Probably, the most important molecu­
lar cytogenetic technique for studying chro­
mosomes in individual cells is interphase flu­
orescence in situ hybridization (FISH) [10]. 
The latter has been already shown to provide 
valuable data on chromosomal mosaicism and 
the contribution to brain pathology in neurode- 
velopmental and neurodegenerative disorders 
[7, 11, 12]. Currently, FISH still represents an 
important technology for studying chromoso­
mal imbalances and chromosome organization 
in interphase nuclei regardless of the introduc­
tion of post-genomic technologies (i.e. next- 
generation sequencing and microarray-based 
methods) [10, 13-15]. The present communica­
tion pays attention to a FISH-based technique 
for studying individual interphase chromo­
somes in their integrity in single cells -  inter­
phase chromosome-specific multicolor band­
ing (ICS-MCB) -  and to the applicability for 
studying neurodevelopmental and neurodegen- 
erative disorders.
ICS-MCB applications.ICS-MCB is a
method combining interphase FISH and multi­
color chromosomal banding (a FISH-based 
approach toward banding several chromoso­
mal regions and subregions smaller than a 
chromosome arm through the use of microdis­
sected DNA probes). The application of ICS- 
MCB on human cellular nuclei provides the 
depiction of homologous interphase chromo­
somes in their integrity at molecular resolution 
(see Iourov et al. [16, 17]). Actually, there is 
no true alternative to this technique for study­
ing human interphase chromosomes in their 
integrity in individual cells [7, 10, 18]. Previ­
ously, ICS-MCB has been applied to identify 
chromosomal abnormalities and instability in 
the diseased human brain. Furthermore, the 
technique might be used for determining nu­
clear chromosome organization in almost all 
human tissues.
Somatic chromosomal mosaicism and 
chromosome instability has been repeatedly 
associated with neurodevelopmental and neu- 
rodegenerative disorders [1, 7, 19, 20]. More 
importantly, these types of genomic variability 
may be confined to the diseased brain. The 
phenomenon of brain-specific chromosomal 
mosaicism seems to play a significant role in 
the etiology of neurodevelopmental and neuro- 
degenerative disorders [3, 7, 19, 21]. For in­
stance, chromosomal instability, a process 
closely related to cancerization, has been un­
covered to mediate neurodegeneration using 
ICS-MCB. Interphase chromosome breaks 
(ICB) have been found to be the commonest 
type of chromosomal instability mediating cer­
ebellar neurodegeneration in ataxia- 
telangiectasia [22]. ICB are currently undetect­
able by any type of molecular (cytogenetic) 
techniques apart from ICS-MCB. Brain-specific 
aneuploidy and copy number variations have
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been shown to be implicated in molecular and 
cellular pathways neurodegeneration [3, 19, 
23]. Aneuploidy of chromosomes 21 and X un­
covered by ICS-MCB has been found to be a 
common mechanism for Alzheimer’s disease, 
one of the commonest neurodegenerative dis­
eases in elderly persons [24-26]. Currently, such 
types of genomic variability are suggested to be 
key elements of the Alzheimer’s disease patho­
genetic cascade [27]. Age-specific chromoso­
mal mosaicism requires to be addressed by 
high-resolution single-cell molecular cytogenet­
ic techniques (i.e. ICS-MCB) [28, 29]. Finally, 
chromosomal instability (chromothripsis) ap­
pears to mediate brain dysfunction in neurode- 
velopmental and neurodegenerative disorders 
[30]. In total, the phenomena identified using 
ICS-MCB have been recognized as genomic 
mechanisms of intercellular genetic variation 
in health and disease [31, 32].
Alternatively, ICS-MCB may be applied 
for studying chromosome arrangement in inter­
phase nuclei [3, 10, 16, 17, 21]. It is to note that 
positioning of chromosomes in the nucleus and 
its impact on transcriptional genome activity 
and genome stability maintenance have not 
been evaluated in the majority of human tissues. 
The application of ICS-MCB would be certain­
ly valuable to fill this gap in our biomedical 
knowledge. It is highly likely that chromosome 
nuclear organization is specific for a variety of 
brain diseases including those leading to neuro- 
developmental and neurodegenerative disor­
ders.
Taking into account previous experience, 
one may define a spectrum of targets for mo­
lecular (neuro) cytognetic studies of neurode- 
velopmental and neurodegenerative disorders 
using ICS-MCB. Figure schematically shows 
these ICS-MCB targets.
Fig. Targets of ICS-MCB in molecular (neuro) cytognetic studies of neurodevelopmental and neu­
rodegenerative disorders (ICS-MCB depiction is from Yurov et al. [26]; licensee BioMed Central 
Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribu­
tion License (http://creativecommons.org/licenses/by/2.0)
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The spectrum of ICS-MCB targets evi­
dences for high applicability of this molecular 
cytogenetic technique for studying brain dis­
eases. Recently, neurodevelopmental and neu- 
rodegenerative disorders have been shown to 
be mediated by a complex pattern of genetic- 
environmental interactions. It is more probable 
that chromosomal abnormalities/instability (i.e. 
aneuploidy and ICB) are important elements of 
the pathogenetic cascade. In other words, envi­
ronmental effects interact with specific ge­
nomic susceptibility to the instability to cause 
aneuploidy and ICB [33]. Nuclear chromo­
some organization might be implicated in 
pathways to neurodevelopmental and neuro- 
degenerative disorders in a similar way. There­
fore, further studies aimed at determination of 
molecular and cellular pathways to neurode- 
velopmental and neurodegenerative disorders 
would benefit from the application of ICS- 
MCB.
Conclusions. The evaluation of ICS- 
MCB applicability shows this technique to of­
fer a unique possibility to address chromoso­
mal instability and nuclear chromosome organ­
ization in human interphase nuclei. Since the 
overwhelming majority of human cells are 
likely to be in interphase, ICS-MCB represents 
an important tool for chromosomal and ge­
nomic research. In summary, complementary 
surveys of molecular and cellular (genetic and 
genomic) mechanisms of neurodevelopmental 
and neurodegenerative disorders are likely to 
require this interphase cytogenetic approach to 
chromosomal analysis.
No conflict o f  interest was recorded 
with respect to this article.
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